Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,147
  • Shares Outstanding, K 40,654
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,955 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.21
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1800 +5.56%
on 12/01/25
0.2800 -32.14%
on 11/24/25
-0.0400 (-17.39%)
since 11/05/25
3-Month
0.1700 +11.76%
on 10/20/25
0.3100 -38.71%
on 10/09/25
-0.0600 (-24.00%)
since 09/05/25
52-Week
0.1700 +11.76%
on 10/20/25
0.7000 -72.86%
on 01/03/25
-0.4600 (-70.77%)
since 12/05/24

Most Recent Stories

More News
Stocks in play: BioVaxys Technology Corp

Announced today that the Company and Horizon Technology Finance Corporation have executed a supplemental ...

BIOV.CN : 0.1900 (-9.52%)
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizon Technology...

BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed its previously announced...

BIOV.CN : 0.1900 (-9.52%)
Stocks in play: BioVaxys Technology Corp

Has announced a consolidation of its issued and outstanding common shares on the basis of one post-consolidated ...

BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ANNOUNCES SHARE CONSOLIDATION

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces, further to its news release dated August 27,...

BVAXF : 0.1498 (-3.91%)
BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ANNOUNCES UNSECURED CONVERTIBLE DEBENTURE OFFERING AND CANCELLATION OF BROKERED LIFE OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to complete a non-brokered...

BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an extension of its previously announced brokered private...

BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ("Enclave") to act as an...

BIOV.CN : 0.1900 (-9.52%)
BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has amended the terms of its brokered private...

BIOV.CN : 0.1900 (-9.52%)
Stocks in play: BioVaxys Technology Corp

Provides a summary of current operating initiatives including the integration and disposition of assets ...

BIOV.CN : 0.1900 (-9.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization,...

See More

Key Turning Points

3rd Resistance Point 0.2233
2nd Resistance Point 0.2167
1st Resistance Point 0.2133
Last Price 0.1900
1st Support Level 0.2033
2nd Support Level 0.1967
3rd Support Level 0.1933

See More

52-Week High 0.7000
Fibonacci 61.8% 0.4975
Fibonacci 50% 0.4350
Fibonacci 38.2% 0.3725
Last Price 0.1900
52-Week Low 0.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar